MA27152A1 - Association d'un inhibiteur de pde4 selectif et d'un agoniste de recepteur beta-2 adrenergique - Google Patents
Association d'un inhibiteur de pde4 selectif et d'un agoniste de recepteur beta-2 adrenergiqueInfo
- Publication number
- MA27152A1 MA27152A1 MA27712A MA27712A MA27152A1 MA 27152 A1 MA27152 A1 MA 27152A1 MA 27712 A MA27712 A MA 27712A MA 27712 A MA27712 A MA 27712A MA 27152 A1 MA27152 A1 MA 27152A1
- Authority
- MA
- Morocco
- Prior art keywords
- pde4 inhibitor
- selective pde4
- receptor agonist
- combination
- beta
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/53—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with three nitrogens as the only ring hetero atoms, e.g. chlorazanil, melamine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
- A61K31/4738—Quinolines; Isoquinolines ortho- or peri-condensed with heterocyclic ring systems
- A61K31/4745—Quinolines; Isoquinolines ortho- or peri-condensed with heterocyclic ring systems condensed with ring systems having nitrogen as a ring hetero atom, e.g. phenantrolines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/02—Nasal agents, e.g. decongestants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/08—Bronchodilators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pulmonology (AREA)
- Engineering & Computer Science (AREA)
- Immunology (AREA)
- Pain & Pain Management (AREA)
- Rheumatology (AREA)
- Otolaryngology (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Medicinal Preparation (AREA)
Abstract
DEPOSANT Société dite : PFIZER INC. REVENDICATION DE PRIORITES GB 7 Décembre 2001 0129395.0 Voir en annexe le titre de l'invention et le texte de l'abrégé Association d'un inhibiteur de PDE4 sélectif, et d'un agoniste de récepteur bêta-2 adrénergique La présente invention concerne une association d'un inhibiteur de PDE4 sélectif, tel que défini dans le présent mémoire, et d'un agoniste de récepteur (bêta)2 adrénergique pour une administration simultanée, séquentielle ou séparée par inhalation dans le traitement d'une maladie obstructive des voies aériennes ou d'une autre maladie inflammatoire.
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB0129395.0A GB0129395D0 (en) | 2001-12-07 | 2001-12-07 | Pharmaceutical combination |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| MA27152A1 true MA27152A1 (fr) | 2005-01-03 |
Family
ID=9927247
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MA27712A MA27152A1 (fr) | 2001-12-07 | 2004-06-02 | Association d'un inhibiteur de pde4 selectif et d'un agoniste de recepteur beta-2 adrenergique |
Country Status (33)
| Country | Link |
|---|---|
| US (2) | US20030119862A1 (fr) |
| EP (1) | EP1455783A1 (fr) |
| JP (1) | JP2005511657A (fr) |
| KR (1) | KR20050044699A (fr) |
| CN (1) | CN1599609A (fr) |
| AP (1) | AP2004003054A0 (fr) |
| AR (1) | AR037712A1 (fr) |
| AU (1) | AU2002353255A1 (fr) |
| BR (1) | BR0214776A (fr) |
| CA (1) | CA2468676A1 (fr) |
| CO (1) | CO5590899A2 (fr) |
| EA (1) | EA200400640A1 (fr) |
| EC (1) | ECSP045142A (fr) |
| GB (1) | GB0129395D0 (fr) |
| HN (1) | HN2002000356A (fr) |
| HR (1) | HRP20040515A2 (fr) |
| HU (1) | HUP0402546A3 (fr) |
| IL (1) | IL162098A0 (fr) |
| IS (1) | IS7277A (fr) |
| MA (1) | MA27152A1 (fr) |
| MX (1) | MXPA04004930A (fr) |
| NO (1) | NO20042870L (fr) |
| NZ (1) | NZ533030A (fr) |
| OA (1) | OA12736A (fr) |
| PA (1) | PA8560601A1 (fr) |
| PE (1) | PE20031066A1 (fr) |
| PL (1) | PL370770A1 (fr) |
| SV (1) | SV2004001430A (fr) |
| TN (1) | TNSN04102A1 (fr) |
| TW (1) | TWI242433B (fr) |
| UY (1) | UY27564A1 (fr) |
| WO (1) | WO2003047578A1 (fr) |
| ZA (1) | ZA200403905B (fr) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20030055026A1 (en) | 2001-04-17 | 2003-03-20 | Dey L.P. | Formoterol/steroid bronchodilating compositions and methods of use thereof |
| TWI359675B (en) * | 2003-07-10 | 2012-03-11 | Dey L P | Bronchodilating β-agonist compositions |
| DE10360954B3 (de) * | 2003-12-23 | 2005-08-18 | Esparma Gmbh | Verwendung von Silibinin, dessen Salzen und/oder dessen Prodrugs zusammen mit α-Liponsäure zur Behandlung chronisch obstruktiver Lungenerkrankungen |
| WO2012098495A1 (fr) * | 2011-01-19 | 2012-07-26 | Glenmark Pharmaceuticals Sa | Composition pharmaceutique qui comprend le revamilast et un agoniste de bêta-2 |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO1996039408A1 (fr) * | 1995-06-06 | 1996-12-12 | Pfizer Inc. | 5,6-DIHYDRO-9H-PYRAZOLO[3,4-c]-1,2-4-TRIAZOLO[4,3-α]PYRIDINES TRICYCLIQUES |
| EP1107747A4 (fr) * | 1998-08-26 | 2003-04-23 | Smithkline Beecham Corp | Compositions pour le traitement de maladies pulmonaires |
| PT1212089E (pt) * | 1999-08-21 | 2006-08-31 | Altana Pharma Ag | Combinacao sinergica de roflumilast e salmeterol |
-
2001
- 2001-12-07 GB GBGB0129395.0A patent/GB0129395D0/en not_active Ceased
-
2002
- 2002-11-22 HU HU0402546A patent/HUP0402546A3/hu unknown
- 2002-11-22 IL IL16209802A patent/IL162098A0/xx unknown
- 2002-11-22 NZ NZ533030A patent/NZ533030A/en not_active IP Right Cessation
- 2002-11-22 CA CA002468676A patent/CA2468676A1/fr not_active Abandoned
- 2002-11-22 BR BR0214776-9A patent/BR0214776A/pt not_active IP Right Cessation
- 2002-11-22 WO PCT/IB2002/004922 patent/WO2003047578A1/fr not_active Application Discontinuation
- 2002-11-22 AU AU2002353255A patent/AU2002353255A1/en not_active Abandoned
- 2002-11-22 PL PL02370770A patent/PL370770A1/xx not_active Application Discontinuation
- 2002-11-22 KR KR1020047008613A patent/KR20050044699A/ko active IP Right Grant
- 2002-11-22 OA OA1200400162A patent/OA12736A/en unknown
- 2002-11-22 MX MXPA04004930A patent/MXPA04004930A/es unknown
- 2002-11-22 EA EA200400640A patent/EA200400640A1/ru unknown
- 2002-11-22 AP APAP/P/2004/003054A patent/AP2004003054A0/en unknown
- 2002-11-22 EP EP02788275A patent/EP1455783A1/fr not_active Withdrawn
- 2002-11-22 CN CNA028243935A patent/CN1599609A/zh active Pending
- 2002-11-22 JP JP2003548833A patent/JP2005511657A/ja not_active Withdrawn
- 2002-12-03 US US10/308,962 patent/US20030119862A1/en not_active Abandoned
- 2002-12-05 AR ARP020104719A patent/AR037712A1/es unknown
- 2002-12-05 HN HN2002000356A patent/HN2002000356A/es unknown
- 2002-12-05 UY UY27564A patent/UY27564A1/es not_active Application Discontinuation
- 2002-12-05 PE PE2002001175A patent/PE20031066A1/es not_active Application Discontinuation
- 2002-12-06 SV SV2002001430A patent/SV2004001430A/es not_active Application Discontinuation
- 2002-12-06 TW TW091135479A patent/TWI242433B/zh not_active IP Right Cessation
- 2002-12-06 PA PA20028560601A patent/PA8560601A1/es unknown
-
2003
- 2003-12-16 US US10/736,996 patent/US20040167153A1/en not_active Abandoned
-
2004
- 2004-05-20 ZA ZA200403905A patent/ZA200403905B/en unknown
- 2004-05-21 IS IS7277A patent/IS7277A/is unknown
- 2004-06-02 MA MA27712A patent/MA27152A1/fr unknown
- 2004-06-04 TN TNP2004000102A patent/TNSN04102A1/fr unknown
- 2004-06-04 CO CO04052217A patent/CO5590899A2/es not_active Application Discontinuation
- 2004-06-07 EC EC2004005142A patent/ECSP045142A/es unknown
- 2004-06-07 HR HR20040515A patent/HRP20040515A2/hr not_active Application Discontinuation
- 2004-07-06 NO NO20042870A patent/NO20042870L/no not_active Application Discontinuation
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Langley et al. | Nimodipine: a review of its pharmacodynamic and pharmacokinetic properties, and therapeutic potential in cerebrovascular disease | |
| MA26955A1 (fr) | INHIBITEURS DES RECEPTEURS EP4 POUR LE TRAITEMENT DE L'ARTHRITE RHUMATOiDE | |
| MA28303A1 (fr) | Derives de sulfonamides pour le traitement de maladies | |
| TNSN01053A1 (fr) | Compositions nouvelles comprenant un agoniste partiel des recepteurs de nicotine et un agent analgesique | |
| MA28435B1 (fr) | Composes d'indazole-carboxamide en tant qu'agonistes de recepteur 5-ht4 | |
| MA27840A1 (fr) | Derives de (2-hydroxy-2-(4-hydroxy-3-hydroxymethylphenyl)-ethylamino)-propylphenyle servant d'agonistes beta2 | |
| MA27190A1 (fr) | Derives de tropane servant de modulateurs de ccr5 | |
| MA27060A1 (fr) | Therapeutique mixte pour le traitement du cancer | |
| MA28284A1 (fr) | Nitro-oxydérivés de prostaglandines | |
| MA25809A1 (fr) | Derives d'arylmethylamine pour usage comme inhibiteurs de tryptase | |
| EA200000299A1 (ru) | Лекарства | |
| MA26874A1 (fr) | Arylpyrazines substituées | |
| MXPA03008955A (es) | Agente terapeutico para enfermedades de tipo artritides cronicas o enfermedades relacionadas con la ninez. | |
| MA27451A1 (fr) | Derives de thiazole pour le traitement de troubles neurodegeneratifs | |
| MA30085B1 (fr) | Traitement du diabete de type 2 avec une association d'un inhibiteur de dpiv et de metformine ou d'une thiazolidinedione | |
| HK1087702A1 (en) | Arylmethylamine derivatives for use as tryptase inhibitors | |
| BR9814923A (pt) | Método para tratamento de doença de alzheimer | |
| MA27142A1 (fr) | Derives de piperazine a activite antagoniste des recepteurs ccr1 | |
| DE60206198T2 (de) | Tetrahydrochinolinderivate als muscarinische agonisten | |
| MA29723B1 (fr) | Composes | |
| MA27671A1 (fr) | Compositions pharmaceutiques comprenant une combinaison de rapamycine ou de son derive et de pimecrolimus pour le traitement de maladies inflammatoires et de maladies induites immunologiquement | |
| MY135838A (en) | Methods for the treatment of mental disorders | |
| MA26953A1 (fr) | Derives de pipérazine pontés. | |
| MY135916A (en) | Use of certain affinity nmda antagonists as antidepressants | |
| MXPA05009986A (es) | Tratamiento de la enfermedad de alzheimer. |